Conference Reports for NATAP

EASL - European Association for the Study of the Liver Barcelona, Spain May 27-30, 2026 Back

Week 48 top-line results from the phase 2b, multicenter, randomized, placebo-controlled IMPACT trial of pemvidutide in metabolic dysfunction-associated steatohepatitis       EASL 2026 May 26-30 Barcelona